CDISC Therapeutic Area Data Standards: User Guide for Breast Cancer (Version 1.0) Â© 2016 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 13 Provisional May 16, 2016 3.3 Pathology Following a biopsy or breast surgery , the resected tissue is examined by a pathologist. Pathologic assessments are both macroscop ic and microscopic , and provide further detail as to the specific type and aggressiveness of the cancer. Concept Map 3: Removal of Cancer Tissue Pathologic assessment of breast cancer include s immunohistochemistry (IHC) as sessment for estrogen receptor (ER) and progesterone receptor (PR) as well as IHC or in situ hybridization (ISH) determination of human epidermal growth factor receptor 2 (HER2) status.9 Other testing, such as that for cancer antigens, may be performed as well. Tumors are also graded based on microscopic appearance (e.g., poorly differentiated or well differentiated).10 Additional genetic